Acid control with esomeprazole and lansoprazole: A comparative dose–response study
Clive H. Wilder‐Smith, Kerstin Röhss(AstraZeneca (Sweden)), Tore Lind(Skaraborg Hospital), Catharina Nilsson-Pieschl(AstraZeneca (Sweden)), Christina Lundin, Emma Nauclér(AstraZeneca (Sweden))
Cited by 22
Related Papers
Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I Study
|Helicobacter|1996|575
The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies
|Gastroenterology|1999|433
Pharmacokinetics and pharmacodynamics of esomeprazole, the S‐isomer of omeprazole
|Alimentary Pharmacology & Therapeutics|2001|175
Comparison of Outcomes Twelve Years After Antireflux Surgery or Omeprazole Maintenance Therapy for Reflux Esophagitis
|Clinical Gastroenterology and Hepatology|2009|150
Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects
|European Journal of Clinical Pharmacology|2000|140